UT News Search Button
2 UT Austin Faculty Members Elected to National Academy of Sciences
Jonathan Sessler and Anthony Di Fiore have been elected members of the National Academy of Sciences.
AUSTIN, Texas Chemist Jonathan L. Sessler and anthropologist Anthony Di Fiore of The University of Texas at Austin have been elected to the National Academy of Sciences. The academy is the country’s most prestigious scientific organization, and election to it is one of the highest honors for American researchers.
The two are among 120 new national inductees announced this week in recognition of distinguished and continuing achievements in original scientific research.
Abeona Therapeutics Appoints Two Industry Leaders as New Independent Members to Its Board of Directors gurufocus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gurufocus.com Daily Mail and Mail on Sunday newspapers.
Message :
Required fields
HOUSTON, April 19, 2021 (GLOBE NEWSWIRE) Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that all three submitted abstracts detailing research involving seclidemstat were accepted for poster presentations, with one abstract also selected for a poster discussion session, at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. ASCO will be held virtually from June 4-8, 2021.
“We are very pleased to report that research involving seclidemstat will be the subject of three poster presentations at the 2021 ASCO Annual Meeting,” stated David Arthur, President and CEO of Salarius Pharmaceuticals. “As previously noted, the full findings from the dose escalation-stage of the Phase 1/2 trial of seclidemstat in patients with relapsed and refractory Ewing sarcoma, including details
Perimeter Medical Imaging AI to Present at 2021 Bloom Burton & Co Healthcare Investor Conference investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
By
Sun Apr 18 2021
A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found.
A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.
The research was published today in Nature Communications.
In the study, investigators reported the extensive presence of mouse viruses in patient-derived xenografts (PDX). PDX models are developed by implanting human tumor tissues in immune-deficient mice, and are commonly used to help test and develop cancer drugs.